Journal for ImmunoTherapy of Cancer (@jitcancer) header
Journal for ImmunoTherapy of Cancer (@jitcancer) profile picture

The official journal of @SITCancer, covering all aspects of tumor immunology and cancer immunotherapy. #JITC Editor-in-Chief: Michael T. Lotze, MD

Milwaukee, WI
Joined July 2019
Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)Photo by Journal for ImmunoTherapy of Cancer (@jitcancer)
New #JITC article: "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of multiple myeloma, version 2.0" jitc.bmj.com/content/14/11/e…
1
357
New #JITC article: "Multi-omics reveals PCSK9 induces precursor-like macrophage M2 polarization to exacerbate immunosuppression in peritoneal metastasis" doi.org/10.1136/jitc-2026-01…
2
2
364
New #JITC article: "Steering the immune response: cancer vaccines and the next era of cancer immunotherapy" doi.org/10.1136/jitc-2026-01…
1
5
24
1,120
New #JITC article: "Integrated tumor and circulating immune profiling in the NEO-CESQ trial of perioperative cemiplimab for resectable cutaneous squamous cell carcinoma" jitc.bmj.com/content/14/11/e…
3
3
477
New #JITC article: "Antiviral humoral immunity as biomarker and effector in oncolytic adenovirus TILT-123 therapy" doi.org/10.1136/jitc-2026-01…
3
2
361
New #JITC article: "Harnessing inflammatory monocytes to overcome resistance to anti-PD-1 immunotherapy" doi.org/10.1136/jitc-2026-01…
10
36
1,589
New #JITC article: "Lost in translation: why cytokine release syndrome reporting fails clinical trials" doi.org/10.1136/jitc-2026-01…
339
New #JITC article: "Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy" doi.org/10.1136/jitc-2026-01…
1
7
357
New #JITC article: "Enhanced melanoma-specific cytotoxic T-cell expansion and the clinical outcomes with simlukafusp alfa and pembrolizumab following checkpoint inhibitor progression" doi.org/10.1136/jitc-2026-01…
2
3
449
New #JITC article: "CD39, CD73, and CD38 track tumor burden and reveal immune remodeling during mogamulizumab therapy in Sézary syndrome" doi.org/10.1136/jitc-2026-01…
2
12
799
Join us for a Meet-the-Editor session! Michael T. Lotze, MD, FAIO, JITC Editor-in-Chief, will be at the SITC booth #827 today from 12:30–1:30 p.m. MT. Stop by to discuss your research, explore publishing opportunities, and connect with the editor behind JITC. We hope to see you there! sitcancer.org/2026/schedule/… #JITC #SITC26 #CancerImmunotherapy
6
390
New #JITC article: "Epigenetic demethylation sensitizes cancer cells to CAR-M triggered pyroptosis and remodels inflammatory immune responses in the tumor microenvironment to potentiate CAR-M cell therapy" doi.org/10.1136/jitc-2026-01…
1
4
14
712
New #JITC article: "Enhanced tumor metastasis driven by the crosstalk between melanoma cells and tumor-associated macrophages: insights into the CXCL10/CXCR3-hnRNP C-MIF axis" doi.org/10.1136/jitc-2026-01…
4
7
466
Join us for a Meet-the-Editor session! Claudia Palena, PhD from National Institutes of Health will be at the SITC booth #827 today from 12:30 PM – 1:30 PM MT. Dr. Palena is the JITC Basic and Translational Cancer Immunology Section Editor as well as the 2026 Pedro J. Romero Service to JITC Award Recipient! Stop by the SITC booth to discuss your research, explore publishing opportunities, and connect with experts in the field. sitcancer.org/2026/schedule/… #JITC #SITC26 #CancerImmunotherapy
1
273
New #JITC article: "Epigenetic targeting of an HBO1-H3K9la-CHI3L1 axis reduces regulatory B cell-mediated CD8+ T cell dysfunction in lung adenocarcinoma" doi.org/10.1136/jitc-2026-01…
4
8
432
The Late-breaking Abstracts (LBAs) from the SITC 2026 Annual Meeting are now publicly available in the Journal for ImmunoTherapy of Cancer (JITC). As the publishing home for SITC's scientific meeting abstracts, JITC is proud to showcase groundbreaking clinical research and late-breaking findings advancing the field of cancer immunotherapy. Explore the Late-breaking Abstracts: info.bmj.com/view/638855727/ #JITC #SITC26 #CancerImmunotherapy
1
4
358
New #JITC article: "Gαi3 acts as a metabolic checkpoint orchestrating TAMs immunosuppression and lipid metabolism in glucose-deprived hepatocellular carcinoma" doi.org/10.1136/jitc-2026-01…
6
10
733
New #JITC article: "Promoting tumor antigen presentation unleashes therapeutic efficacy of Tgfbr2-deficient TCR-engineered T cells in pancreatic ductal adenocarcinoma" doi.org/10.1136/jitc-2026-01…
3
21
1,154
New #JITC article: "Spatial architecture of the tumor–stroma interface and transcriptional programs shape immunotherapy response in MSI-H gastrointestinal cancers" doi.org/10.1136/jitc-2026-01…
11
39
2,695
New #JITC article: "Epigenetic repression of oncogenic signaling defines immune-permissive tumor states associated with response to immune checkpoint inhibitors in advanced NSCLC" doi.org/10.1136/jitc-2026-01…
1
4
7
514